Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AEMD vs $AXNX | Chartloom

Compare

$AEMD vs $AXNX

Aethlon Medical Inc · Axonics Inc

AEMD

Aethlon Medical Inc

AXNX

Axonics Inc

Compare $AEMD vs $AXNX

Comparing Aethlon Medical Inc and Axonics Inc

AEMDAethlon Medical Inc

AXNXAxonics Inc

AEMDAethlon Medical Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

96.5%

YTD performance

-60.4%

52W performance

-83.9%

FCF yield

-49.0%

AXNXAxonics Inc

Market cap

$36M

P/E (TTM)

—

Forward P/E (NTM)

1.40x

Forward P/S (NTM)

0.07x

Rev growth (TTM)

26.1%

YTD performance

-0.1%

52W performance

-98.8%

FCF yield

14.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEMD

AXNX

Not enough overlapping price history for this window.

Detailed metrics comparison

AEMD

Aethlon Medical Inc

AXNX

Axonics Inc

Market Cap

AEMD$15M

AXNX$36M

Enterprise Value

AEMD$10M

AXNX$-203M

Price

AEMD$5.58

AXNX$0.71

P/E Ratio

AEMDN/A

AXNXN/A

P/S Ratio

AEMD17.03x

AXNX0.08x

EV/Sales

AEMD8.37x

AXNX-0.47x

EV/EBITDA

AEMD0.00x

AXNX-58.64x

P/B Ratio

AEMD1.87x

AXNX0.02x

P/FCF Ratio

AEMDN/A

AXNX6.75x

EV/FCF

AEMD-1.35x

AXNX-37.80x

PEG Ratio

AEMDN/A

AXNXN/A

Forward P/E (NTM)

AEMDN/A

AXNX1.40x

Forward P/S (NTM)

AEMDN/A

AXNX0.07x

Revenue (TTM)

AEMD$0

AXNX$432M

Revenue Growth (YoY)

AEMD96.5%

AXNX26.1%

Forward Rev Growth

AEMD170.9%

AXNX0.0%

Gross Margin (TTM)

AEMD0.0%

AXNX76.6%

Operating Margin (TTM)

AEMD0.0%

AXNX0.0%

EBITDA Margin (TTM)

AEMD0.0%

AXNX1.2%

Net Margin (TTM)

AEMD0.0%

AXNX-1.3%

FCF Margin (TTM)

AEMDN/A

AXNX1.2%

Net Income (TTM)

AEMD$-7M

AXNX$-6M

FCF (TTM)

AEMD$-7M

AXNX$5M

EPS (TTM)

AEMD-$18.03

AXNX-$0.11

ROE (TTM)

AEMD-12309.0%

AXNX-88.0%

ROA (TTM)

AEMD-9929.0%

AXNX-77.0%

ROIC (TTM)

AEMD-12309.0%

AXNX-88.0%

Cash

AEMD$5M

AXNX$239M

Debt

AEMD$0

AXNX$0

Net Cash/Debt

AEMD$5M

AXNX$239M

Current Ratio (TTM)

AEMD5.42x

AXNX8.16x

Quick Ratio (TTM)

AEMD5.14x

AXNX6.33x

Debt/Equity (TTM)

AEMD0.00x

AXNX0.00x

Debt/Assets (TTM)

AEMD0.0%

AXNX0.0%

Interest Coverage (TTM)

AEMDN/A

AXNXN/A

Net Debt/EBITDA (TTM)

AEMD0.00x

AXNX0.00x

Beta

AEMD1.20

AXNX3.24

52W Performance

AEMD-83.9%

AXNX-98.8%

YTD Performance

AEMD-60.4%

AXNX-0.1%

% from 52W High

AEMD-84.5%

AXNX-99.0%

% from 52W Low

AEMD295.7%

AXNX1.4%

Asset Turnover (TTM)

AEMD0.03x

AXNX0.58x

FCF Yield (TTM)

AEMD-49.0%

AXNX14.8%

Earnings Yield (TTM)

AEMD-47.3%

AXNX-15.6%

Dividend Yield (TTM)

AEMDN/A

AXNXN/A

Rule of 40

AEMD96.6

AXNX27.3

EV/GP/RG

AEMDN/A

AXNXN/A

Ticker research

View AEMD research View AXNX research

Metric	AEMD Aethlon Medical Inc	AXNX Axonics Inc
Market & Valuation
Market Cap	$15M	$36M
Enterprise Value	$10M	$-203M
Price	$5.58	$0.71
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	0.08x
EV/Sales	8.37x	-0.47x
EV/EBITDA	0.00x	-58.64x
P/B Ratio	1.87x	0.02x
P/FCF Ratio	N/A	6.75x
EV/FCF	-1.35x	-37.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	1.40x
Forward P/S (NTM)	N/A	0.07x
Revenue & Growth
Revenue (TTM)	$0	$432M
Revenue Growth (YoY)	96.5%	26.1%
Forward Rev Growth	170.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	76.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	1.2%
Net Margin (TTM)	0.0%	-1.3%
FCF Margin (TTM)	N/A	1.2%
Net Income (TTM)	$-7M	$-6M
FCF (TTM)	$-7M	$5M
EPS (TTM)	-$18.03	-$0.11
ROE (TTM)	-12309.0%	-88.0%
ROA (TTM)	-9929.0%	-77.0%
ROIC (TTM)	-12309.0%	-88.0%
Financial Health
Cash	$5M	$239M
Debt	$0	$0
Net Cash/Debt	$5M	$239M
Current Ratio (TTM)	5.42x	8.16x
Quick Ratio (TTM)	5.14x	6.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.24
52W Performance	-83.9%	-98.8%
YTD Performance	-60.4%	-0.1%
% from 52W High	-84.5%	-99.0%
% from 52W Low	295.7%	1.4%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.58x
FCF Yield (TTM)	-49.0%	14.8%
Earnings Yield (TTM)	-47.3%	-15.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	27.3
EV/GP/RG	N/A	N/A
Ticker research	View AEMD research	View AXNX research

Valuation

P/S Ratio

AXNX

0.08x

AEMD

17.03x

EV/FCF

AXNX

-37.80x

AEMD

-1.35x

Growth & revenue

Revenue Growth TTM

AEMD

96.5%

AXNX

26.1%

Forward Revenue Growth

AEMD

170.9%

AXNX

0.0%

Profitability & performance

Gross Margin

AXNX

76.6%

AEMD

0.0%

ROE

AXNX

-88.0%

AEMD

-12309.0%

FCF Yield %

AXNX

14.8%

AEMD

-49.0%

52-Week Performance

AEMD

-83.9%

AXNX

-98.8%

Detailed metrics comparison

AEMD

Aethlon Medical Inc

AXNX

Axonics Inc

Market Cap

AEMD$15M

AXNX$36M

Enterprise Value

AEMD$10M

AXNX$-203M

Price

AEMD$5.58

AXNX$0.71

P/E Ratio

AEMDN/A

AXNXN/A

P/S Ratio

AEMD17.03x

AXNX0.08x

EV/Sales

AEMD8.37x

AXNX-0.47x

EV/EBITDA

AEMD0.00x

AXNX-58.64x

P/B Ratio

AEMD1.87x

AXNX0.02x

P/FCF Ratio

AEMDN/A

AXNX6.75x

EV/FCF

AEMD-1.35x

AXNX-37.80x

PEG Ratio

AEMDN/A

AXNXN/A

Forward P/E (NTM)

AEMDN/A

AXNX1.40x

Forward P/S (NTM)

AEMDN/A

AXNX0.07x

Revenue (TTM)

AEMD$0

AXNX$432M

Revenue Growth (YoY)

AEMD96.5%

AXNX26.1%

Forward Rev Growth

AEMD170.9%

AXNX0.0%

Gross Margin (TTM)

AEMD0.0%

AXNX76.6%

Operating Margin (TTM)

AEMD0.0%

AXNX0.0%

EBITDA Margin (TTM)

AEMD0.0%

AXNX1.2%

Net Margin (TTM)

AEMD0.0%

AXNX-1.3%

FCF Margin (TTM)

AEMDN/A

AXNX1.2%

Net Income (TTM)

AEMD$-7M

AXNX$-6M

FCF (TTM)

AEMD$-7M

AXNX$5M

EPS (TTM)

AEMD-$18.03

AXNX-$0.11

ROE (TTM)

AEMD-12309.0%

AXNX-88.0%

ROA (TTM)

AEMD-9929.0%

AXNX-77.0%

ROIC (TTM)

AEMD-12309.0%

AXNX-88.0%

Cash

AEMD$5M

AXNX$239M

Debt

AEMD$0

AXNX$0

Net Cash/Debt

AEMD$5M

AXNX$239M

Current Ratio (TTM)

AEMD5.42x

AXNX8.16x

Quick Ratio (TTM)

AEMD5.14x

AXNX6.33x

Debt/Equity (TTM)

AEMD0.00x

AXNX0.00x

Debt/Assets (TTM)

AEMD0.0%

AXNX0.0%

Interest Coverage (TTM)

AEMDN/A

AXNXN/A

Net Debt/EBITDA (TTM)

AEMD0.00x

AXNX0.00x

Beta

AEMD1.20

AXNX3.24

52W Performance

AEMD-83.9%

AXNX-98.8%

YTD Performance

AEMD-60.4%

AXNX-0.1%

% from 52W High

AEMD-84.5%

AXNX-99.0%

% from 52W Low

AEMD295.7%

AXNX1.4%

Asset Turnover (TTM)

AEMD0.03x

AXNX0.58x

FCF Yield (TTM)

AEMD-49.0%

AXNX14.8%

Earnings Yield (TTM)

AEMD-47.3%

AXNX-15.6%

Dividend Yield (TTM)

AEMDN/A

AXNXN/A

Rule of 40

AEMD96.6

AXNX27.3

EV/GP/RG

AEMDN/A

AXNXN/A

Ticker research

View AEMD research View AXNX research

Metric	AEMD Aethlon Medical Inc	AXNX Axonics Inc
Market & Valuation
Market Cap	$15M	$36M
Enterprise Value	$10M	$-203M
Price	$5.58	$0.71
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	0.08x
EV/Sales	8.37x	-0.47x
EV/EBITDA	0.00x	-58.64x
P/B Ratio	1.87x	0.02x
P/FCF Ratio	N/A	6.75x
EV/FCF	-1.35x	-37.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	1.40x
Forward P/S (NTM)	N/A	0.07x
Revenue & Growth
Revenue (TTM)	$0	$432M
Revenue Growth (YoY)	96.5%	26.1%
Forward Rev Growth	170.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	76.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	1.2%
Net Margin (TTM)	0.0%	-1.3%
FCF Margin (TTM)	N/A	1.2%
Net Income (TTM)	$-7M	$-6M
FCF (TTM)	$-7M	$5M
EPS (TTM)	-$18.03	-$0.11
ROE (TTM)	-12309.0%	-88.0%
ROA (TTM)	-9929.0%	-77.0%
ROIC (TTM)	-12309.0%	-88.0%
Financial Health
Cash	$5M	$239M
Debt	$0	$0
Net Cash/Debt	$5M	$239M
Current Ratio (TTM)	5.42x	8.16x
Quick Ratio (TTM)	5.14x	6.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	3.24
52W Performance	-83.9%	-98.8%
YTD Performance	-60.4%	-0.1%
% from 52W High	-84.5%	-99.0%
% from 52W Low	295.7%	1.4%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.58x
FCF Yield (TTM)	-49.0%	14.8%
Earnings Yield (TTM)	-47.3%	-15.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	27.3
EV/GP/RG	N/A	N/A
Ticker research	View AEMD research	View AXNX research